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Strengths and limitations of this study
 ► Despite the heterogeneity of the intervention repeat-
edly being cited as a limiting factor in evaluations of 
intervention efficacy, no previous study that we are 
aware of has systematically mapped the variety of 
emotional disclosure (ED)-based interventions, out-
come measures and theoretical frameworks used in 
the palliative care setting.
 ► A rigorous, systematic approach will be applied 
to searching, screening, extracting and analysing 
the literature based on established scoping review 
methodological approaches.
 ► There may be challenges in identifying studies due 
to the differences in terms used to describe ED-
based interventions.
 ► The review will be limited to studies of adult popula-
tions and published in the English language.
 ► The studies included in the review will not be ap-
praised for methodological quality as this is outside 
the remit of scoping review methodology.
ABSTRACT
Introduction Emotional disclosure (ED) is a term used 
to describe the therapeutic expression of emotion. ED 
underlies a variety of therapies aimed at improving 
well-being for various populations, including people with 
palliative-stage disease and their family carers. Systematic 
reviews of ED-based psychotherapy have largely focused 
on expressive writing as a way of generating ED. However, 
heterogeneity in intervention format and outcome 
measures has made it difficult to analyse efficacy. There is 
also debate about the mechanisms proposed to explain the 
potential effects of ED.
We present a scoping review protocol to develop a 
taxonomy of ED-based interventions to identify and 
categorise the spectrum of interventions that could 
be classified under the umbrella term of ‘emotional 
disclosure’ in the palliative care setting. By mapping these 
to associated treatment objectives, outcome measures 
and explanatory frameworks, the review will inform future 
efforts to design and evaluate ED-based therapies in this 
population.
Methods and analysis The review will be guided 
by Arksey and O’Malley’s five-stage scoping review 
framework and Levac’s extension. The following electronic 
databases will be searched from database inception: 
CENTRAL, the Cumulative Index to Nursing and Allied 
Health Literature (CINAHL), PsycINFO, Scopus, Web of 
Science and MEDLINE. We will include peer-reviewed 
studies and reviews. We will also check grey literature, 
including clinical trial registers, conference proceedings 
and reference lists, as well as contacting researchers. 
Articles will be screened by at least two independent 
reviewers and data charted using an extraction form 
developed for this review. Results will be analysed 
thematically to create a taxonomy of interventions, 
outcome measures and theoretical frameworks.
Ethics and dissemination This review does not require 
ethical approval as it is a secondary analysis of pre-
existing, published data. The results will inform future 
research in the development of ED-based interventions 
and evaluation of their efficacy in the palliative care 
setting. We will disseminate findings through peer-
reviewed journals.
InTRoduCTIon
People living with a terminal illness often 
experience significant psychological, 
emotional and physical discomfort.1 2 Family 
carers are also likely to experience psycho-
logical distress during and after supporting a 
relative through advanced illness.2–4 Palliative 
care services aim to holistically address the 
physical, psychological and other needs of 
patients with advanced, life-limiting illness.5 
Psychotherapies form one important element 
of this palliative treatment approach.6–8 
However, access to such therapies in this 
setting is restricted by issues arising from 
limited availability of qualified professionals 
and evidence-based interventions well-
adapted to the population.9 10 Funding also 
poses a potential challenge, with a 2015 
survey of hospices in the UK identifying 
significant concerns over freezing or reduc-
tion of statutory funding, and warning of 
its adverse effects on hospice services.11 12 
Furthermore, guidelines for the provision of 
psychological services in this population are 
limited. The National Institute of Health 
and Care Excellence last published guidance 
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on structuring psychological support in palliative care 
for adults in 2004 and only in cancer. It is not clear how 
widely these guidelines have been followed.9 13 Indeed, a 
recent survey of clinical psychologists working in hospices 
in the UK indicated there is significant variability in how 
psychological support is provided.9 Palliative care physi-
cians also report limited access to psychological services 
for patients.14 Taken together, this suggests that palliative 
care services might benefit from access to simple inter-
ventions that can be delivered by non-specialist health-
care practitioners, and with the potential for volunteer 
involvement. This could supplement the support offered 
by specialist practitioners to clinically distressed patients 
with complex needs.
Emotional disclosure (ED) is a term used to describe the 
therapeutic expression of emotions. This flexible therapy 
holds potential to be harnessed as a relatively low-cost, 
simple intervention in certain formats, such as expres-
sive writing (EW).15 Its flexibility also means it could be 
adapted to the specific needs of patients at a palliative 
stage of disease, for example, by modifying the method 
used to generate emotional expression (eg, typing or 
spoken disclosure). ED has long been a critical concept 
associated with the talk-based psychotherapies pioneered 
by Freud in the early 1900s.15 However, rigorous research 
into the concept and associated therapies was relatively 
scant until the 1980s.15 In 1986, Pennebaker and Beall 
introduced their influential EW intervention, which was 
designed to generate ED and led to a rapid expansion of 
research into this topic.15 16 EW typically involves partic-
ipants writing about their emotions associated with a 
traumatic experience for 15–20 min over 3–5 consecutive 
days. Since the introduction of Pennebaker and Beall’s 
EW intervention, the format has been widely adapted to 
explore the boundary conditions of the intervention.16–19 
For example, tasks to induce ED have included writing 
about positive emotions or future goals, or spoken disclo-
sure.18–23 Poetry therapy is also recognised as an adap-
tation of the original EW paradigm.22 24 Moreover, ED 
is recognised as a fundamental part of other forms of 
psychotherapy, such as music therapy25 and art therapy.26 
In recent times, patients and family members are increas-
ingly turning to blogging, social media and chatroom 
sites to disclose emotions around their experiences of 
their illness.27–29
The existence of numerous formats of ED-based thera-
pies and behaviours complicates the process of exploring 
if and how such interventions might work. Yet, a clear 
understanding of the mechanisms linking cause and 
effect is considered fundamental to the development and 
study of complex interventions.30 31 In the case of ED, 
there is unlikely to be a single underlying process, rather 
a framework of interacting mechanisms.19 32 33 Processes 
that have been proposed to explain EW have been 
reviewed and include emotional inhibition, cognitive 
adaptation, exposure and emotional regulation,19 32 33 yet 
no consensus has been reached on a unifying framework. 
Different methods of generating ED are also likely to 
invoke different or overlapping processes. For instance, 
disclosure through EW may employ mechanisms related 
to language processing34–36 and ED through art may func-
tion through sensory and motor processes.37 Disclosure 
via online forums is likely to involve many of the mecha-
nisms involved in social support.38–40 Moreover, the ther-
apeutic setting may influence which cognitive processes 
are initiated by ED. For instance, for patients at the palli-
ative stage of disease, the potential effects of ED may be 
mediated by mechanisms related to meaning, control or 
closure in ways that may not occur in a healthy popula-
tion.41 42
Mirroring the unclear processes underlying ED, the 
efficacy of ED-based therapies remains uncertain. In 
general populations, a meta-analysis of 146 studies iden-
tified a small but significant positive effect of ED-based 
interventions on both physical and psychological health 
outcomes in healthy populations.43 It has been suggested 
that moderators, such as demographic, personality and 
existing emotional support, are also likely to influence the 
efficacy of ED-based therapies, highlighting the impor-
tance of targeting and tailoring such interventions.43 
In people receiving palliative care, evidence of efficacy 
also remains unclear. Much of the literature is focused 
on EW and reports mixed results. A recent systematic 
review and meta-analysis of four randomised controlled 
trials (RCTs) that examined EW in patients with advanced 
disease found it did not have a significant effect on any 
of the selected health-related outcomes.44 However, the 
review also reported more promising results from studies 
that conducted linguistic analyses of EW in this popula-
tion; these analyses identified that use of certain words, 
such as positive emotion words, was related to better 
emotional well-being.45 They also found EW writers 
used more cognitive words associated with causal under-
standing, which the authors reported suggested cognitive 
changes.46 Other related reviews have also uncovered 
mixed results. A systematic review of EW in patients with 
breast cancer (irrespective of stage) found the interven-
tion reduced negative somatic symptoms at a 3 month 
follow-up, although it had no effect on psychological 
outcome measures.47 Another review48 assessing EW in a 
variety of cancers of all stages reported 6 of 13 studies as 
finding statistically significant, small to moderate bene-
fits of EW on energy and sleep patterns,49 depressive50 
and physical symptoms,50 51 emotional support,52 pain,53 
uptake of mental health services54 and healthcare utilisa-
tion.51 However, each of the 13 studies also reported some 
null effects, and the authors were unable to conduct a 
meta-analysis due to the heterogeneity of interventions 
and outcome measures used across the studies. A further 
review of EW in cancer populations found no evidence 
of EW efficacy on psychological, physical or quality of 
life outcomes,55 while a review of therapeutic writing in 
patients with long-term illnesses also found no effects.22 
None of the studies of EW in populations with advanced 
disease reported significant negative effects, with the 
exception of Low et al (2010), who found women who 
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had been diagnosed with metastatic cancer for ≥4.7 
years exhibited greater sleep disturbance following EW, 
whereas those more recently diagnosed did not.56
Such mixed results are also characteristic of other 
ED-based interventions in clinical populations. A prelim-
inary scoping of the literature indicates that reviews of 
studies of explicitly ED-based interventions in the pallia-
tive care setting are lacking. However, individual studies 
have identified some benefits in this population. Kissane 
et al (2007) found supportive-expressive group therapy 
improved quality of life and treatment of depression in 
women with metastatic breast cancer.57 Clements-Cortes 
found patients with a terminal illness were able to 
decrease depressive symptoms and social isolation and 
enhance relaxation by expressing their emotions through 
music therapy.58 Indeed, a recent review of music therapy 
in patients receiving palliative care found it had a posi-
tive effect on pain, fatigue, anxiety and quality of life.59 
Given the heterogeneity of interventions included in 
the review, however, not all included interventions were 
necessarily designed specifically to evoke ED. Reviews 
of ED-based interventions in clinical populations with 
serious (although not explicitly palliative-stage) disease 
have identified mixed results. A systematic review of 52 
trials reported that music interventions may have benefi-
cial effects on anxiety, pain, fatigue and quality-of-life for 
people with cancer (of all stages), but that results were 
inconsistent across trials.60 They also noted that, when 
asked, participants said they valued the opportunity for 
emotional expression and processing offered by the 
therapy. A further systematic review of creative psycho-
logical interventions (CPIs), which encompass the use 
of music, art, drama and dance/movement to express 
and process thoughts and emotions, found evidence of 
psychological but not physical benefits of CPIs across 
10 trials in cancer patients.61 Similarly, ED-based inter-
ventions in bereaved family members have also demon-
strated mixed results,62 63 although they have been less 
widely studied in this group than in patients.
While the efficacy of ED-based therapies in the palli-
ative care setting remains uncertain, current reviews 
recommend further research to assess the true efficacy of 
each intervention.22 44 47 48 55 60 61 This is due to a number 
of limitations of the current literature. First, current 
reviews are significantly limited by the heterogeneity of 
the format of interventions and outcome measures used 
across the studies they are reviewing.22 44 47 48 55 60 61 Second, 
and tellingly, qualitative interviews show participants find 
certain interventions valuable, even where null effects 
are captured by quantitative measures.48 60 This suggests 
current studies are not necessarily investigating the 
outcome measures that convey the benefit experienced 
by patients, which may be more abstract or existential 
in nature, particularly in patients with a palliative-stage 
disease.48 64 Third, authors have noted a lack of effort to 
tailor interventions to the specific needs of people with 
advanced or terminal illness.22 44 48 This could encom-
pass, for example, offering audio recorded disclosure 
as an alternative to written disclosure in EW studies, as 
some patients may lose the ability to write. Finally, meth-
odological quality of studies included in the systematic 
reviews has been largely graded as low, with limitations 
due to sample size, methodological features, such as lack 
of randomisation and data reporting. In light of these 
significant limitations to existing research, future studies 
should aim to address these shortfalls. The broad nature 
of therapeutic ED, however, makes future research design 
challenging. This is due, in part, to the significant overlap 
of terms being used to describe various interventions, and 
a lack of clarity on the most appropriate format, outcome 
measures and underlying mechanisms.
To address these shortcomings, we plan to use scoping 
review methodology to conduct an explorative, yet 
systematic, investigation of the existing heterogeneous 
literature. Scoping review methodology can be used to 
clarify and map out complex concepts in a robust and 
replicable manner.65–67 It is therefore a suitable method 
through which to identify, consolidate and categorise the 
existing literature into a taxonomy of ED-based inter-
ventions in the palliative care setting. Such a taxonomy 
will provide researchers with a framework to inform the 
design of future studies of ED-based interventions, by 
guiding selection of intervention format and outcome 
measures. Moreover, the taxonomy will map intervention 
efficacy, along with any reported facilitators and barriers, 
to intervention format, to help draw out potential mech-
anisms of action. If researchers use the taxonomy to 
inform study design, this should in turn lay the ground-
work for more informative systematic reviews of ED-based 
interventions. Given the unique physical, psychological 
and emotional position (eg, in terms of needs and expe-
riences) of patients at the palliative stage of disease and 
their family carers, the scope of this review will be limited 
to research conducted in the palliative care setting. 
However, these findings could also provide a springboard 
to help develop a taxonomy for ED-based interventions in 
other populations.
objectives
Primary objective
To develop a taxonomy of ED-based interventions used 
in the palliative care setting, for people with advanced 
diseases and their family carers. The taxonomy will iden-
tify, categorise and define classes of intervention that fall 
under the umbrella term of ‘emotional disclosure’.
Secondary objective
To map classes of intervention defined in the taxonomy 
to (1) underlying mechanisms, (2) appropriate treatment 
objectives, (3) outcome measures, (4) any facilitators and 
barriers to intervention feasibility and (5) efficacy.
METhodS And AnAlySIS
This protocol is guided by the standard framework 
proposed by Arksey and O’Malley66 and expanded by 
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Table 1 Timeline for protocol and scoping review.
Month (2019)
January February March April May June July August September
October
→
Stage 1: identifying research 
question and writing protocol
Stage 2: identifying relevant 
studies (search)
Stage 3: study selection 
(screening)
Stage 4: data charting
Stage 5: collating, 
summarising and reporting 
results
Stage 6: consultation Throughout process at key stages
(protocol development, screening and collating results)
Cells shaded grey indicate the proposed timeline for completion of each stage.
Levac and colleagues65 and the Joanna Briggs Institute.67 
These guidelines recommend organising the scoping 
review process into at least five stages, with an optional 
sixth stage:
 ► Stage 1: identifying the research 
question(s)—complete.
 ► Stage 2: identifying relevant studies.
 ► Stage 3: study selection.
 ► Stage 4: charting the data.
 ► Stage 5: collating, summarising and reporting the 
results.
 ► Stage 6: consultation.
The protocol has also been developed in line with 
scoping review best practice, as summarised in the 
completed Preferred Reporting Items for Systematic 
Reviews and Meta-Analyses for Protocols and Scoping 
Reviews included in online supplementary file 1 . 
Table 1 summarises the proposed timescale for the 
review.
Stage 1: identifying the research question
To meet the objectives of the review, as outlined above, 
we will seek to thematically analyse insights from the 
following research questions:
 ► Which psychotherapeutic interventions delivered in 
patients at the palliative stage of disease and their 
family carers are categorised as, or explicitly grounded 
in, principles of ED? For example, what format are 
the interventions, how often are they delivered and 
by whom?
 ► What are the primary objectives of ED-based inter-
ventions delivered in this setting? For example, to 
enhance overall quality of life, physical or psycholog-
ical health.
 ► What outcome measures are used to assess the efficacy 
of ED-based interventions in this setting?
 ► What theoretical frameworks are used to explain the 
mechanisms underlying ED-based interventions in 
this setting?
 ► What are the facilitators and barriers to ED-based 
intervention feasibility and efficacy in this setting?
Stage 2: identifying relevant studies
The following inclusion criteria were developed in collab-
oration with key stakeholders, including physicians, 
psychologists and family carers involved in the provision 
of palliative care. Throughout the screening and data 
extraction process the criteria will be discussed within the 
research team and updated where necessary to ensure all 
relevant literature is being captured.65
 ► Studies must use or make reference to a psychotherapeutic 
intervention that the authors state:
 – involves ‘emotional disclosure’ or involves a task 
that requires participants to express or communi-
cate feelings or emotions
 – as a core or critical element of the therapy
 – and that aims to improve some aspect of patient or 
carer well-being.
 ► Articles published in the English language (to prevent 
issues with intricacies of translation interfering with 
an effective definition of key terms).
 ► The majority of the population of interest are adult partici-
pants (aged 18 and above):
 – With a diagnosis of an advanced disease (eg, end-
stage organ failure or advanced/metastatic/incur-
able cancers), and/or being explicitly treated with 
a palliative intent OR
 – Family carers of patients at a palliative stage of a 
disease.
 – Based on previous related reviews44 that indicated 
that few studies meet these criteria, samples which 
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included >50% patients with advanced-stage dis-
ease will also be included.
 ► All types of original research from within the peer-reviewed 
medical and nursing, psychological and social science liter-
ature will be included, including RCTs, comparative 
studies (eg, non-randomised experiments, before-
and-after studies), qualitative studies, case studies, 
ethnographies and diary studies.
 ► Peer-reviewed conference abstracts of papers not published 
in full will also be included if they are sufficiently 
detailed.
 ► Review articles that discuss ED as a psychotherapeutic 
intervention and make explicit mention of its use in 
the palliative care setting (or in patients with advanced 
disease and/or their family carers), including: 
systematic reviews, meta-analyses, meta-syntheses, 
scoping reviews, narrative reviews, rapid reviews, crit-
ical reviews and integrative reviews, opinion pieces, 
commentaries and editorial reviews.
Exclusion criteria
The following resources will be excluded from data 
extraction and analysis:
 ► Studies with tasks that were not designed to be 
emotionally expressive, or which do not list ED (or 
similar) as a key feature of the intervention.
 ► Non peer-reviewed sources (eg, some book chap-
ters and dissertations/theses); however, we will scan 
reference lists of relevant resources, and/or contact 
authors where appropriate.
No date limits will be applied to the searches, in order to 
capture the breadth of ED-based therapy delivery beyond 
the introduction of the well-cited EW paradigm in 1986.16
Databases
The following electronic databases will be searched from 
database inception to March 2019: the CINAHL, Cochrane 
Central Register of Controlled Trials (CENTRAL), 
PsycINFO, Scopus, Web of Science and MEDLINE. We will 
also check the European Union Clinical Trials Register, 
clinicaltrials. gov, the European Association for Palliative 
Care and British Psychological Society (BPS) conference 
abstract proceedings for the last 7 (2012–2018) and 17 
years (2001–2018), respectively. In addition, we will check 
the reference lists of relevant studies, review articles, book 
chapters and theses to identify further relevant citations. 
Finally, we will contact researchers who have expressed 
an interest in the field, via a research list compiled by 
the BPS, to ask if they are aware of any studies that may 
be relevant to this review. In case of uncertainty, authors 
of relevant studies will be approached to clarify whether 
studies meet the inclusion criteria for this review.
Search strategy
The search strategy is based on an earlier systematic 
review exploring EW as a psychotherapeutic intervention 
in patients with advanced disease.44 The search terms 
have been expanded to capture ED-based therapies more 
broadly, as well as including terms for advanced disease 
and palliative care. See online supplementary file 2 for 
an example search strategy used in the Ovid MEDLINE 
database that will be modified for each database, utilising 
keywords, MeSH terms and Boolean operators as appro-
priate. As per Levac and colleagues65 recommendation 
for an iterative search strategy development process, we 
will review the search criteria throughout the screening 
process to update, expand or limit the search if required.
Stage 3: study selection
The research team will meet to discuss preliminary inclu-
sion and exclusion criteria during the protocol develop-
ment phase. At least two reviewers will independently 
screen citations for inclusion to full article review stage. 
Reviewers will meet at the beginning, midpoint and final 
stages of the abstract review process to discuss challenges 
and uncertainties related to study selection, and to refine 
the search strategy and inclusion criteria if needed. Full 
article review will also be carried out independently by 
two researchers for articles which meet the inclusion 
criteria, or have unclear relevance during the screening 
phase. Where disagreements arise around inclusion, a 
third reviewer will be consulted to resolve disputes.
Stage 4: charting the data
The research team will collectively develop the data-
charting form based on the variables most relevant to the 
research questions. The form will be piloted using five 
articles, and the process and data-fields discussed between 
the research team prior to conducting the full data 
extraction procedure. Following full data extraction, the 
data from each independent reviewer will be compared 
and any discrepancies discussed to achieve consistency 
between reviewers.
A preliminary data extraction framework has been 
developed, tailored to answer each of the pre-defined 
research questions. Along with basic bibliographic infor-
mation, information will be extracted about the study 
design, patient population, intervention characteris-
tics, intervention objectives, outcome measures, under-
lying theoretical frameworks, intervention efficacy and 
proposed rationale for efficacy. A draft data-charting 
form for primary experimental studies is included in 
online supplementary file 3.
Stage 5: collating, summarising and reporting the results
As per the guidelines of Levac and colleagues,65 this stage 
will be conducted in three phases:
1. Analysis: to include both descriptive, quantitative anal-
ysis (eg, number of relevant studies within each inter-
vention type; sample demographics) and qualitative 
thematic analysis (to explore how different ED-based 
interventions may be classified by format, objectives 
and/or other characteristics to inform the taxonomy).
2. Reporting the results of the analysis and producing the 
outcomes that refer to the study’s research question(s).
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3. Considering the meanings of the findings as they relate 
to the overall study purpose, and discussing the impli-
cations for future research, practice and/or policy.
Thematic analysis will be applied to understand the 
core, defining characteristics of each ED-based inter-
vention.68 From this analysis, we will work to develop a 
taxonomy of ED-based interventions. Thematic analysis 
of the objectives, outcomes and mechanisms will also be 
conducted, to enable us to map them onto intervention 
types. Exploratory analysis of facilitators, barriers and 
efficacy of specific interventions will also be conducted. 
We will examine whether there are any specific types of 
intervention that appear in studies using robust designs 
(eg, RCTs) to produce higher proportions of positive 
outcomes associated with specific outcome measures. We 
will also examine whether these patterns of efficacy are 
related to specific facilitators or barriers. The aim of this 
analysis will be to provide an indication of the reported 
efficacy and setting-specific requirements, with the inten-
tion of providing insights into the most useful direction 
for future work.
Results will be reported as tables, graphs and descriptive 
themes as appropriate. As well as reporting a taxonomy of 
ED-based interventions in the palliative care context, we 
will also discuss how it can be used to help guide future 
research into and implementation of ED-based psycho-
therapy in this setting.
Stage 6: consultation
Although not mandated by the Arksey and O’Malley66 
framework, in the extension developed by Levac and 
colleagues65 consultation with key stakeholders who may 
provide insights beyond the literature is essential. The 
research team who contributed to the development of 
this protocol includes a range of key stakeholders who 
will be engaged throughout the review process (including 
a palliative care consultant, a psychiatrist and researchers 
with expertise in EW, palliative care research and system-
atic review processes). An advisory group will also be 
consulted throughout the review process, including 
protocol development, results analysis and development 
of resulting conclusions and recommendations. The 
group includes health psychologist (Dr Nick Troop), clin-
ical psychologist (Dr Penny Rapaport), former patient 
carer (Mr Peter Buckle) and evidence synthesis method-
ologist and palliative care nurse (Dr Kate Flemming).
PATIEnT And PuBlIC InvolvEMEnT
As described in stage 6 (consultation), Mr Peter Buckle is 
a member of the advisory group. Peter has lived experi-
ence of caring for his wife throughout her terminal illness. 
He is a member of the Marie Curie Research Expert 
Voices Group, a group of volunteers with personal expe-
riences of living with terminal illness who support Marie 
Curie’s research activities. Peter’s insights will be used 
throughout the review process, including development of 
the research protocol, results analysis and dissemination.
EThICS And dISSEMInATIon
We present a protocol for a comprehensive and rigorous 
scoping review of ED-based interventions used in patients 
and family carers in the palliative care setting. The results 
will be disseminated through traditional routes, including 
peer-reviewed journals, local and international confer-
ences on palliative care and health psychology, and press 
releases, social media and blogs as appropriate. Through 
effective dissemination, the results of the review should 
help to inform more effective development, study and 
review of ED-based therapies in this patient population.
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